You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

12 Results
Guidelines and Advice
Status: Current
ID: 4-17
Version: 2
Jan 2018
Guidelines and Advice
Status: In-Review
ID: 4-8
Version: 4
Jul 2019
Guidelines and Advice
Status: Current
ID: 8-6
Version: 2
Aug 2018
Guidelines and Advice
Status: Current
ID: SCT-2
Version: 2
Nov 2019
Guidelines and Advice
Status: In-Review
ID: 12-12-2
Version: 2
Nov 2018
Regimen
Cancer Type:
Hematologic, 
Leukemia - Acute Myeloid (AML)
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative
Drugs Used:
SORAfenib (Unfunded)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2019
Guidelines and Advice
Status: In-Review
ID: 6-13
Mar 2018
Guidelines and Advice
Status: Current
Version: 1
Jun 2018
Guidelines and Advice
Status: Current
ID: N/A
Version: 1
Nov 2018
Cancer facts
Jun 2019
Guidelines and Advice
Status: Current
Sep 2019
Statistical Reports
Jan 2018